Safety and effectiveness of disease-modifying therapies after switching from natalizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 

Authors & Co-authors:  Zeineddine Maya M Al-Roughani Raed R Farouk Ahmed Samar S Khoury Samia S El-Ayoubi Nabil N Al-Mahdawi Akram A Al-Khabouri Jaber J Al-Asmi Abdullah A Chentouf Amina A Inshasi Jihad J

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 2022

Authors & Co-authors:  Signori Alessio A Lorscheider Johannes J Vukusic Sandra S Trojano Maria M Iaffaldano Pietro P Hillert Jan J Hyde Robert R Pellegrini Fabio F Magyari Melinda M Koch-Henriksen Nils N

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 

Authors & Co-authors:  Dekeyser Cathérine C Hautekeete Matthias M Cambron Melissa M Van Pesch Vincent V Patti Francesco F Kuhle Jens J Khoury Samia S Lechner Scott Jeanette J Gerlach Oliver O Lugaresi Alessandra A